Shares of Evotec SE (OTCMKTS:EVTCY – Get Free Report) crossed above its 50 day moving average during trading on Tuesday . The stock has a 50 day moving average of $3.86 and traded as high as $4.16. Evotec shares last traded at $4.12, with a volume of 192,035 shares traded.
Evotec Price Performance
The company has a market capitalization of $1.36 billion, a P/E ratio of 10.05 and a beta of 0.98. The business’s 50-day simple moving average is $3.86 and its 200 day simple moving average is $4.11. The company has a current ratio of 2.57, a quick ratio of 2.50 and a debt-to-equity ratio of 0.53.
About Evotec
Evotec SE engages in the discovery and development of new drugs for pharmaceutical and biotechnology companies. It operates through the following segments: EVT Execute and EVT Innovate. The EVT Execute segment provides stand-alone or integrated drug discovery solutions for collaborators targets and programmers on a typical fee-for-service basis or through a variety of commercial structures, which may include performance-based components, such as milestones and royalties.
Read More
- Five stocks we like better than Evotec
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- AppLovin Dips on S&P 500 Snub, Morgan Stanley Lifts Target Anyway
- Using the MarketBeat Stock Split Calculator
- Casey’s Surges on Strong Q4, More Gains Likely Ahead
- What Are Some of the Best Large-Cap Stocks to Buy?
- Government Mandate Sends eVTOL Stocks Flying
Receive News & Ratings for Evotec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evotec and related companies with MarketBeat.com's FREE daily email newsletter.
